-
Combination therapy as initial treatment in glaucoma and suspected glaucoma
14 May 2012
Frederick S. Mikelberg, Mahyar Etminan
Abstract: Objective: We hypothesize that there may be an inappropriate overuse of initial combination therapy in patients with glaucoma and in those who are glaucoma suspects. To test this hypothesis,...
-
The 1-year incidence of rhegmatogenous retinal detachment post 23-gauge pars plana vitrectomy
14 May 2012
Mahta Rasouli, Stratton M. Steed, Matthew T.S. Tennant, Chris J. Rudnisky, Brad J. Hinz, Mark D.J. Greve, Rizwan Somani
Abstract: Objective: The purpose of this study was to evaluate the 1-year incidence of retinal tear or retinal detachment following 23-gauge pars plana vitrectomy (PPV) for epiretinal membrane (ERM), ...
-
Canadian expert consensus: optimal treatment of neovascular age-related macular degeneration
14 May 2012
Alan F. Cruess, Alan Berger, Kevin Colleaux, Mark Greve, Patricia Harvey, Peter J. Kertes, Thomas Sheidow, Eric Tourville, Geoff Williams, David Wong
Abstract: Background: New therapeutic approaches, particularly anti-vascular endothelial growth factor (anti-VEGF) therapies, prevent, and in some cases reverse, vision damage caused by age-related ma...
-
De-insurance in Ontario has reduced use of eye care services by the socially disadvantaged
14 May 2012
Ya-Ping Jin, Yvonne M. Buys, Wendy Hatch, Graham E. Trope
Abstract: Objective: Effective November 1, 2004, the Ontario Ministry of Health and Long-Term Care de-insured, or delisted, routine eye examinations for Ontarians aged 20 to 64 years. We examined whet...
-
Plasma antiphospholipid antibody levels in age-related macular degeneration
14 May 2012
Berna Özkan, Levent V. Karabaş, Özgül Altıntaş, Gülden Sönmez Tamer, Nurşen Yüksel, Yusuf Çağlar
Abstract: Purpose: To investigate the association of age-related macular degeneration (AMD) with plasma antiphospholipid antibody levels. Methods: This prospective study included 19 patients diagnosed...
View More Articles in Press...